Dynamic changes in serum IL-6, TNF-&lt;i&gt;α&lt;/i&gt;, and β2-microglobulin as early predictors of post-treatment relapse in lymphoma: a prospective cohort study. This evidence concerns the gene IL6 and lymphoma.